𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Natalizumab for moderate to severe Crohn's disease in clinical practice: The Mayo Clinic Rochester experience

✍ Scribed by S.V. Kane; S. Horst; W.J. Sandborn; B. Becker; B. Neis; M. Moscandrew; K.A. Hanson; W.J. Tremaine; D.H. Bruining; W.A. Faubion; D.S. Pardi; W.S. Harmsen; A.R. Zinsmeister; E.V. Loftus

Book ID
112101325
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
726 KB
Volume
18
Category
Article
ISSN
1078-0998

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Adalimumab for Crohn's disease in clinic
Adalimumab for Crohn's disease in clinical practice at Mayo clinic: The first 118 patients
✍ Jason M. Swoger; Edward V. Loftus Jr.; William J. Tremaine; William A. Faubion; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 132 KB πŸ‘ 1 views

## Background: We sought to assess the effectiveness and safety of adalimumab for the treatment of Crohn's disease (CD) in clinical practice. Methods: Demographic, clinical, and treatment data were abstracted from the medical record. The primary outcome was clinical response to induction therapy